viability by spect -...
TRANSCRIPT
DISCLOSURES - Honorarium – Research / Advisor, Expert Services and Conferences in Nuclear Cardiology
BMS, CVT, Astellas, Lantheus, PGx Health, International Atomic Energy Agency
Royalties – Publications in Nuclear Cardiology Springer-Verlag-Nuclear Cardiology and Correlative Imaging: a teaching file, NY, 2004 Lippincott Williams & Wilkins, - Nuclear Medicine teaching File, 2009
João V. Vitola
Quanta Diagnostico Nuclear
Brazil
Viability by SPECT
65 yo male Atypical chest pain No history of CAD/MI HTN, hypercholesterolemia
Vitola and Delbeke: Nuclear Cardiology and Correlative Imaging, Springer 2004, NY, Chapter 3
Case
SAV – EXERCISE SAV - REST
VLA – EXERCISE VLA - REST
HLA – EXERCISE HLA - REST
1- Does the ECG change represents a silent MI in the past ? 2- Does he need any additional viability study ?
Myocardial Viability: 99mTc-perfusion agents
• Retention of MIBI and tetrofosmin depends on cell membrane integrity and mitochondrial function.
• 99mTc-perfusion agents do not redistribute and may underestimate viability compared to 201Tl or FDG
• Improvement for detection of viability with quantitative SPECT criteria and nitrate administration
Cuocolo A et al. J Nucl Med 1992;33:505-51 Soufer R et al. Am J Cardiol 1995;75:1214-1 Altehoefer C et al. J Nucl Med 1994;35:569-
Conclusions • TMT was less sensitive than MPI for LCX
ischemia detection • CAD and prior MI detected in a patient with no
history • MIBI was consistent with rest ECG, confirming
the suspicion of a prior silent MI • MIBI detected a large area of viable tissue at
risk, not requiring any other test to decide management
• MIBI can be used as a viability agent, however underestimation of viable tissue may occur in some cases and further testing may be needed
Case • 68 year-old woman with a history of
silent inferior MI who presented with episodes of atrial fibrillation and ventricular tachycardia
• ECG: – Q waves in II, III, AVF
• Coronary angiography: – Occluded RCA with collaterals to the distal
inferior wall from the left circulation
Rest only - 15 min Rest- 4h redistribution 201Tl
Membrane Integrity: Thallium-201 • Analog of potassium
– Myocardial extraction by active and passive transport
– High first pass uptake – 89% – Myocardial localization: 4% injected dose
• Does redistribute according to perfusion • Allows evaluation of perfusion and cell
membrane integrity (a requirement for viability)
Vitola and Delbeke: Nuclear Cardiology and Correlative Imaging, Springer 2004, NY, Chapters 3 and 8
Membrane Integrity: 201Thallium SPECT Rest-4h redistribution - Semiquantitation
• Patterns of uptake in dysfunctional myocardium: – Fixed defect: <50% of normal:
transmural scar – Fixed defect: 50-80% of normal: non-
transmural scar – Redistribution – Myocardium at risk -
viable
Bax JJ et al. Eur J Nucl Med 1997;24:516-522.
Membrane Integrity: 201Thallium SPECT • Stress/Rest imaging
– 4-hour redistribution imaging: • fixed defect frequently viable: 45% of fixed
defects improve after revascularization.
– Resting imaging after reinjection of 201Tl improves viability assessment : 30-50% fixed defects at 4h redistribution show reversibility.
– 24-h redistribution imaging (in average additional 6%)
Kiat H et al. JACC 1988;12:1456-1463. Yang LD et al. JACC 1990;15:334-340. Dilsizian V et al. NEJM 1990;323:141-146.
Value of 24h imaging: Small number of patients:
– Up to 30% of patients with fixed defects (rest-4 hrs) will show improved uptake at 24h
– But only 3% of patients with fixed defects of <50% uptake of normal
Membrane Integrity: 201Thallium SPECT
Wagdy HM et al. Nucl Med Commun 2002;23:629-637. Matsunari I et al. J Nucl Med 1997;38:1073-1078.
Does a Fixed Defect on Rest / Stress Tc-99m Sestamibi Study Underestimate Myocardial
Ischaemia?
Comparison with 24 Hr Tl-201 Study with Short-term follow-
up
Dr G. Kong, Dr D. Gunawardana, Dr M. Lichtenstein, Dr K. Roysri, Dr N. Better,
Dr D. Sivaratnam
Nuclear Medicine Department, The Royal Melbourne Hospital, Grattan Street, Parkville, Victoria.
Clin Nuc Med ….March 2008
Methods • Prospective study • 50 consecutive pts • Accrued March 2005 – July 2005
• Patients with
– Fixed defects on MIBI – High clinical suspicion of reversible ischemia
•Received additional thallium study
Endpoints
3 and 6 months post-scan 1. Acute myocardial infarction (AMI) 2. Unstable angina requiring admission 3. Cardiac Intervention (CABG / PCI) 4. Cardiac Death • Medical records / Treating physician
Tl reversibility
69% (34/49) with fixed MIBI defects showed additional reversibility
Number of patients
Total 49
No reversibility 15 (31%)
Reversibility 34 (69%)
Case MIBI: Fixed inferior, lateral and antero-lateral wall defects
Delayed Tl: Significant reversibility
Cardiac Events 6 months
n = 1 AMI n = 4 USA (3 PCI) n = 6 3 CABG 3 PCI No Cardiac Deaths
P = 0.027
32%
11/34
1/15
• 61 yo man with exercise induced chest pain (typical angina) • AMI 2 1/2 y ago, followed by CABG: LIMA to LAD and SVG to the LCX
• Last cath 6 mo ago: 99% native LAD, occluded LIMA, antero-apical akinesia
•Meds: Carvedilol, ACEI, nitrate, ASA, Statin and Aldactone
Referred for a SESTAMIBI study
•MPI: Bruce, 10 METS, ECG positive – new ST depression 1 mm, denied chest pain
Case
Stress/Rest MIBI • Hx of exercise induced chest pain + new ST depression 1 mm om TMT
Stress/Rest MIBI
•exercise induced chest pain, new ST depression
Next Step ?
Nitrate administration
Venodilation Preload reduction
Decrease of LV volume and wall stress Reduction of myocardial oxygen demand
Coronary blood flow redistribution towards ischemic regions by reduction of LV end-diastolic pressure
Nitrate Myocardial Perfusion Imaging
0 5 10 15 20 25 30 50 70
SPECT imaging
Nitrateadministration
Tracerinjection
Resting conditions
Time (min)
MIBI with nitroglycerin (NTG)
Scar > Ischemia MIBI without NTG
Ischemia > Scar MIBI with NTG
STRESS
STRESS
REST
STRESS
REST
STRESS
REST
•exercise induced chest pain, new ST depression
Next Step : nitrate MIBI = good choice
REST
Rest without NTG Rest with NTG
STRESS STRESS
REST REST
Akinetic antero - apical region
Case
• 52 year-old man with CHF and global LV dysfunction on echocardiography
• Coronary angiography: severe 3-vessel CAD
• Nitrate: How does it work? – Preload reduction, some dilatation of stenotic epicardial
vessel and improvement of collateral circulation • How to administer?
– 0.4-0.8 mg sublingually 5 -10 min before the radiopharmaceutical
• Can be used with 201Tl or 99mTc-perfusion agents • Performance?
Myocardial Viability Resting and nitrate-enhanced SPECT
Bisi G et al. JACC 1994;24:1282-1289. Batista JF et al. J Nucl Cardiol 1999;6:480-486. Oudiz RJ et al. Am Heart J 1999;138:206-209.
FDG
Viable Necrotic
Via
ble 75
(57%)34
(26%)
3(2%)
Nec
rotic 19(15%)
Baseline Tetrofosmin
Agreement: 94/131 (72%)Kappa = 0.35
Nitrate Tetrofosmin
FDG
Viable Necrotic
Via
ble 89
(68%)20
(15%)
3(2%)
Nec
rotic 19
(15%)
Agreement: 109/131 (82%)Kappa = 0.53
Cardiac Tomography After Nitrate Administration in Patients With Ischemic LV Dysfunction: Relation to Metabolic Imaging by PET
He W, et al. J Nucl Cardiol 2003
Cardiac Tomography After Nitrate Administration in Patients With Ischemic LV Dysfunction: Relation to Metabolic Imaging
by PET
He W, et al. J Nucl Cardiol 2003
Patient 1 Patient 2
69
8681 86
0
20
40
60
80
100
Sensitivity SpecificityHe W, et al. J Nucl Cardiol 2003
Per
cent Baseline
Nitrate
Sensitivity and Specificity of Baseline and Nitrate Tetrofosmin SPECT for Detecting Preserved Metabolic Activity in Patients With Ischemic LV Dysfunction
p < 0.01 p = NS
Detection of Myocardial Viability by Radionuclide Imaging Gold Standard: Recovery of LV Function
90 8681
91 92
54
6760
88
73
0
20
40
60
80
100
Tl-201 Red Tl-201 Rein Mibi Mibi-Nitrate FDG-PETBax et al. J Am Coll Cardiol 1997
%
Sensitivity Specificity
Stunning
Scar from prior MI
Hibernation
Subendocardium 20-30 % = akinesia May have lots of viable tissue
Chronic cases = Mixed pattern
Lieberman AN et al, Circulation 1981;63:739-746
Contribution of the subendocardium to contractility
Akinetic anterior wall
Pooled Data from Studies Focusing on Prediction of Recovery of Function Post-revascularization
Technique #Studies/ patients
Sensitivity Specificity NPV PPV
FDG PET 20/598 93% 58% 86% 71%
201Tl 33/858 87% 55% 81% 64%
99mTc-tracers 20/488 81% 66% 77% 71%
Dobutamine Echo/MRI
32/1090 81% 80% 85% 77%
Pooled data 105/3034 84% 69%
Bax JJ et al. Curr Probl Cardiol 2001;26:142-186
Why is nuclear less specific compared to echo for Fx improvement ?
Qureshi U et al. Circulation 1997;95:626-635
Subendocardium MI may lead to akinesia Akinetic segments may have lots of viable tissue detected by Nuclear Scar may prevent improvement of function and detection by echo
• FDG is taken up by viable myocardial regions even when flow is significantly reduced.
• Effectively differentiates nontransmural MI from hibernating condition.
• Soft tissue attenuation correction is routinely performed.
PET FDG for Viability Assessment Advantages over SPECT
• PET FDG is the preferred imaging method for assessment of myocardial viability.
• If SPECT is done first, PET should be considered in those with non- or partially reversible defects.
PET vs. SPECT for Viability Assessment
Conclusions
• MIBI can be used as a viability agent, however underestimation of viable tissue may occur and further testing may be needed in special cases
• Nitrates are easy and safe to use and increase the sensitivity of rest MIBI to detect viable tissue
• There are data in the literature supporting the use of Nitrate MPI with similar accuracy to other protocols including thallium and FDG (LV Fx dependent)
• Akinetic areas may be present after a subendocardium MI
• Viability studies may show large quantities of viable tissue at risk in akinetic areas